Editor's Note This study (CRISTAL randomized trial) from Australia finds that aspirin compared with enoxaparin resulted in significantly higher rates of venous thromboembolism (VTE) after total hip or knee arthroplasty. This cluster-randomized, crossover trial included 9,711 patients in 31 hospitals in Australia—5,675 in the aspirin group and 4,036 in the…

Read More

Editor's Note This study by researchers at the University of Minnesota, Minneapolis, finds that patient treatment at hospitals dedicated to COVID-19 care was associated with lower in-hospital mortality. Of 5,504 patients with COVID-19 analyzed, 2,077 were treated at one of two COVID-19 dedicated hospitals, and 3,427 were treated at other…

Read More

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

Editor's Note The Food and Drug Administration (FDA), on November 30, identified the worldwide recall by Teleflex of its Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7FR as Class I, the most serious. The device, which is used for mechanical declotting of native arteriovenous fistulae and synthetic dialysis grafts, was…

Read More

Editor's Note The Joint Commission on September 8 announced that it has returned to the original volume eligibility requirement for its advanced Thrombectomy-Capable Stroke Center (TSC) and Comprehensive Stroke Center (CSC) certification programs, effective September 1. Volume eligibility requirements were lowered in 2020 and into 2021 because of the COVID-19…

Read More

Editor's Note This study led by researchers at University Hospital Birmingham, UK, finds that COVID-19 is associated with a significantly increased risk of postoperative venous thromboembolism (VTE). This analysis of more than 128,000 patients at 1,630 hospitals in 115 countries found that the likelihood of postoperative VTE was 50% higher…

Read More

Editor's Note The US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), on April 23, announced that after a thorough safety review, the pause on the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine should be lifted, and use of the vaccine should resume. The pause was…

Read More

Editor's Note This multicenter retrospective study led by researchers from George Washington University School of Medicine, Washington, DC, found that aspirin use by COVID-19 patients was associated with improved outcomes. Of 412 COVID-19 patients included in the study, 314 (76.3%) did not receive aspirin, and 98 (23.7%) received aspirin within…

Read More

Editor's Note In this study led by researchers from the University of Maryland School f Medicine, Baltimore, hospitalized COVID-19 patients who took low-dose aspirin daily for their heart health had a 47% lower risk of dying in the hospital than those who did not take aspirin. This retrospective analysis of…

Read More

Editor's Note This study from researchers at the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, finds that COVID-19 is associated with large blood clots in the lower extremities and a significantly higher rate of amputation and death. In March and April 2020, 16 COVID-19-positive patients had…

Read More